Greece is among a number of European countries who are challenging drugs companies by slashing prices as Europe’s drugs bill has risen by 50% in real terms (inflation stripped out) in a decade.
Related posts:
- European Commission proposes better financial terms for EU loans to Ireland and Portugal
- US real estate investment performance in 2010 delivered third strongest annual returns over the last decade
- UK Budget: VAT to rise to 20%; Ex-health, budgets of government departments to be cut 25% in real terms in 4 years
- Global Corporate R&D: Top EU firms cut investment less than US rivals but Europe still well behind; 3 European and US companies in top 10
- European Commission says real GDP projected at 1.8% in the EU27 and 1.7% in the Eurozone in 2010